Life Sciences Network marcus evans

evolution summit marcus evans clinical trials drug development drug discovery pharma drug trials pharmaceutical marketing pharmaceutical pharma evolution alexander fetkovsky pharmamarketing summit clinical development discovery summit evolution life sciences drug evolution sanaclis inc. evolution summits marketing veristat pharmaceuticals deepen patel topstone research sonia sethi kenneth kaitin interview clinical research janssen pharmaceuticals erwin de beuckelaer clinical trial operations clinical trial supply chain kristine koontz jim fratantonio alkermes tom mccourt ironwood pharmaceutical telemedicine biopharma biotech court square group inc. keith parent decentralized trials icon plc hybrid trials eb mclindon patient enrollment dyania health eirini schlosser roman hrynchuk clinical trial patient recruitment ind application fda kevin hennegan kathleen boruchowski medical monitors fox chase cancer center ipsen risk based monitoring lori tierney allergan ascendis pharma dunya botetzayas risk-based monitoring clinical studies chief marketing officer cmo pharma industry clinical study feasibility process clinical study evolution asia abbvie pharma r&d big-data opportunities kyle holen clinical trials in europe cros clinical study metrics clinical trial data management mark wingertzahn glaxosmithcline patient centricity evolution europe steven fruchtman onconova therapeutics patient records chitra lele drug safety clinical study health patient emrollment graeme ladds drug safety data pharsafer topstone research inc clicnical trials pharma discovery kelley kendle synchrogenix evolution summit 2015 idiopathic pulmonary fibrosis boehringer ingelheim pharmaceuticals andreas grauer amgen tufts center eisai pharmceuticals johan luthman gary romano johnson and johnson visiopharm image analysis drug development challenges tufts clinart mena alaa assem business development activities interview - clinar lundbeck interactive corporation drugdev sanaclis s.r.o. conducting clinical trials in emerging markets wit marcus evans evolution summit 2015 clinical trial efficiency should be a key focus suvro ghosh clinzen llc acurian roger smith why quantitative comparison of patient recruitment staffan gestrelius capish where marcus evans fits in our business developmen syndax hematology oncology drug development biomarkers clinical trial standardization primorus clinical trials localization biorasi multitouch marketing pharmaceutical development hispanic patients maximizing procedure site identification patient recruitment & retention biomedical research pharmabrand summit medication administration long-term care cxo summit patient recruitment forest research institute ind global regulatory strategy new drug development cta translational medicine non-porfits medical research foundation disease treatment modeling and simulation technologies in silco to in vivo optimized drug development drug discovery summit pharma marketing chief marketing officers cmos pharmabrand bayer pharmaceuticals summit